Latest Options News

AVADA Group reported a 10.5% revenue decline in FY2025 amid operational consolidation and leadership changes, while conducting a strategic review of its New Zealand operations. Despite setbacks, the company remains cautiously optimistic about future growth.

Vintage Energy has signed a conditional agreement to acquire Metgasco's 25% interest in key Southern Flank gas joint ventures, aiming to accelerate production and value creation from the Vali and Odin fields.

Titan Minerals reports significant wide zones of porphyry-hosted gold-silver-copper mineralisation at its Dynasty Gold Project in Ecuador, with a resource update expected in early 2026.

Clover Corporation delivered a robust FY25 with strong second-half sales and operational milestones, positioning itself for continued growth in FY26 amid ongoing innovation and market expansion.

Tartana Minerals partners with Alt Resources in a $2 million joint venture to accelerate exploration of critical metals in Far North Queensland, focusing on tin, tungsten, and rare earth elements.

Koonenberry Gold’s latest drilling at the Enmore Gold Project reveals visible gold in the first two Phase II holes, extending the mineralised system to 425 metres vertically. The discovery highlights ongoing potential with assays pending and further drilling underway.

SRJ Technologies has partnered with CAPSA Engineering in a $23.8 million joint venture to deliver critical electrical asset integrity services for a Middle Eastern National Oil Company, marking a major step in its regional expansion.

Mayne Pharma updates investors on the extended FIRB approval deadline and potential financing hurdles in its proposed acquisition by Cosette Pharmaceuticals.

Beacon Minerals has declared a fully franked dividend of $0.05 per share, reflecting its robust cash position and confidence in ongoing growth projects. The dividend combines a regular and special payout, signalling strong financial health amid advancing operations.

Middle Island Resources announces the immediate resignation of CEO Roland Bartsch, with the company opting to pay out his full notice period and his unlisted options lapsing as per contract terms.

Tryptamine Therapeutics has enrolled its second patient in a pioneering clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with first dosing scheduled for December and results expected early next year.

Alcoa Corporation has updated its dividend announcement to clarify currency exchange rates and payment options for its upcoming quarterly dividend, ensuring shareholders understand their payment choices and tax obligations.